GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

EVIO EVIO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2022

Revenue

$1.6m

FY2014FY2022

Net income

$48,000

FY2014FY2022

Free cash flow

−$719,000

FY2014FY2022

Shareholders' equity

−$12.7m

FY2014FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$1.6m$2.4m$3.6m$3.4m$3.4m$3.0m$560,961$125,199—
Operating income−$1.4m−$3.8m−$4.2m−$8.2m−$8.2m−$2.1m−$792,548−$1.3m−$643,476
Net income$48,000−$965,000−$8.4m−$11.6m−$11.6m−$3.6m−$2.5m−$1.5m−$643,476
Diluted earnings per share0.00-0.00-0.08-0.21-0.66-0.30-0.30-0.36-0.22

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$1.3m$5.3m$7.7m$14.4m$14.4m$6.0m$2.2m$728,723—
Cash and short-term investments$5,000$12,000$196,601$81,736—$121,013$57,486$25,966—
Total liabilities$13.7m$19.8m$24.1m$10.4m$10.4m$5.8m$2.6m$443,435$56,289
Debt$7.8m$12.7m$15.0m$6.9m$6.1m$4.4m$334,980$38,438$10,000
Shareholders' equity−$12.7m−$14.2m−$16.4m$2.0m$3.9m$67,317−$594,980$188,171−$56,289
Shares outstanding18,284m18,284m109m54m18m12m9m4m3m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$652,000$129,000−$2.0m−$4.4m−$4.4m−$587,665−$276,951−$194,734−$124,800
Capital spending−$67,000−$8,000−$60,226−$1.4m−$1.4m−$253,046−$13,451−$5,694−$2,194
Free cash flow−$719,000$121,000−$2.0m−$5.8m−$5.8m−$840,711−$290,402−$200,428−$126,994

Latest quarters

By quarter end

Dec 2022Sept 2020Jun 2020Mar 2020Dec 2019Sept 2019Jun 2019Mar 2019
Revenue$615,000$792,042$603,192$766,088$1.3m$1.1m$1.2m$735,179
Operating income$191,000−$685,160−$305,855$5.7m−$1.2m−$1.6m−$1.7m−$1.7m
Net income$51,000−$1.8m−$2.1m−$12.8m−$2.3m−$1.4m−$2.6m−$3.9m
Diluted earnings per share0.00-0.02-0.02-0.12-0.04-0.02-0.05-0.07
Cash from operations—−$1.0m———−$1.0m——
Total assets$953,000$7.7m$6.9m$8.4m$8.1m$16.3m$17.6m$17.0m
Cash and short-term investments$6,000$196,601$71,396$110,325—$61,064$210,084—
Debt$1.8m$7.2m$12.1m$11.5m$4.7m$10.0m$8.1m$7.7m
Shareholders' equity−$13.2m−$16.4m−$14.7m−$11.6m−$11.9m−$2.6m$672,476−$2.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-22.1%-12.0%—
Operating income-44.7%-7.7%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%1500%6871947673500%45411%-83%-94%-83%-44%-60%1499%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 6 Sept 2017
  • 2000-to-1 reverse split · 16 Feb 2007
  • 3000-to-1 reverse split · 14 Feb 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.